Skye Bioscience SKYE
NASDAQ SKYE
$1.68 +0.08 (+5.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Price to Earnings (2019 - 2020)

Updated

Skye Bioscience's (SKYE) Price to Earnings came in at 1.02 for Q1 2020, down 93.9% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Price to Earnings (2019 - 2020) Analysis & Trends

For FY2019, Skye Bioscience's Price to Earnings stood at 16.83.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Skye Bioscience 7.03 Mn 7.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 1.02
Dec 31, 2019 16.83
API Access

Skye Bioscience Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SKYE&period=max&api_key=YOUR_API_KEY